Happy Friday all,
Neuren Pharmaceuticals Ltd (ticker = NEU) just made an interesting announcement re their Phase 2 trial, viz;
- showing safe & efficacious result during the stage 2 trials;
- has orphan drug designation from US FDA
- targets an area of high (& urgent) unmet need, even though it only impacts a small global market (10 to 20,000 patients pa)
Clearly, there are parallels with this great biz ($1.6Bn market cap) and our "yet to be great biz", but holy moly the signs are positive given the facts & similarities.
Surely we must be close to a similar news announcement with our very own Prescient !!
Break out the popcorn, the FDA are getting busy....may we follow soon !!
Go Aussie pharma !!
Dr Y
Happy Friday all,Neuren Pharmaceuticals Ltd (ticker = NEU) just...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $31.40M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.1¢ | 3.9¢ | $72.73K | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 436541 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 560576 | 1 |
View Market Depth
| Last trade - 15.59pm 15/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |